New approaches for treatment in diabetes: aldose reductase inhibitors.
Hotta
N
N
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors* / Q000502:physiology / Q000627:therapeutic use*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000503:physiopathology; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D006801:Humans
D000449:Aldehyde Reductase